GoodRx Holdings (GDRX) Other Operating Expenses (2019 - 2026)

GoodRx Holdings (GDRX) has 8 years of Other Operating Expenses data on file, last reported at $123.0 million in Q1 2026.

• For the quarter ending Q1 2026, Other Operating Expenses rose 3.52% year-over-year to $123.0 million; the trailing twelve-month figure through Mar 2026 stood at $426.0 million (down 29.46% YoY), and the FY2025 full-year result was $474.4 million, down 2.16% from the prior year.
• Other Operating Expenses improved to $123.0 million in Q1 2026, from $119.2 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $306.4 million in Q4 2024 to a low of $58.7 million in Q1 2022.
• A 5-year average of $107.1 million and a median of $109.9 million in 2023 frame the typical range for Other Operating Expenses.
• Across the five-year window, Other Operating Expenses surged 161.49% in 2022 and slumped 61.09% in 2025, its largest moves.
• Tracing GDRX's Other Operating Expenses over 5 years: stood at $69.7 million in 2022, then surged by 118.95% to $152.5 million in 2023, then jumped by 100.88% to $306.4 million in 2024, then tumbled by 61.09% to $119.2 million in 2025, then grew by 3.17% to $123.0 million in 2026.
• Business Quant data shows GDRX's Other Operating Expenses at $123.0 million in Q1 2026, $119.2 million in Q4 2025, and $65.9 million in Q3 2025.